UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 303

Sortiert nach

Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population

Hepatology communications, 2022-02, Vol.6 (2), p.399-410

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia

Blood, 2020-08, Vol.136 (7), p.909-913

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia

Nature communications, 2022-03, Vol.13 (1), p.1434-1434, Article 1434

2022

Link zum Volltext

Verfügbarkeit prüfen

A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype

Haematologica (Roma), 2021-04, Vol.106 (4), p.1188

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.106-106, Article 106

2022

Link zum Volltext

Verfügbarkeit prüfen

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.49-49, Article 49

2023

Link zum Volltext

Verfügbarkeit prüfen

Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers

Mayo Clinic proceedings, 2020-07, Vol.95 (7), p.1482-1498

2020

Link zum Volltext

Verfügbarkeit prüfen

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Blood cancer journal (New York), 2017-09, Vol.7 (9), p.e607-e607

2017

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.26-26, Article 26

2022

Link zum Volltext

Verfügbarkeit prüfen

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.54-54, Article 54

2021

Link zum Volltext

Verfügbarkeit prüfen

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"

Blood cancer journal (New York), 2022-04, Vol.12 (4), p.55-55, Article 55

2022

Link zum Volltext

Verfügbarkeit prüfen

P1323: PREDICTION OF NON‐RELAPSE MORTALITY BY EASIX AND HCT‐CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1208-1209

2022

Link zum Volltext

Verfügbarkeit prüfen

Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations

American journal of hematology, 2023-06, Vol.98 (6), p.951-964

2023

Link zum Volltext

Verfügbarkeit prüfen

P730: GENETIC LANDSCAPE OF SOMATIC MYELOID MUTATIONS IN THE PRESENCE OF RARE TERT VARIANTS AND THEIR RELATION WITH MYELOID NEOPLASIA

HemaSphere, 2022-06, Vol.6, p.625-626

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation

Leukemia & lymphoma, 2022-07, Vol.63 (8), p.1792-1800

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Heterogeneity of the VEXAS Syndrome: A Case Series

Mayo Clinic proceedings, 2021-10, Vol.96 (10), p.2653-2659

2021

Link zum Volltext

Verfügbarkeit prüfen

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT‐NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

HemaSphere, 2022-06, Vol.6, p.443-444

2022

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders

Current hematologic malignancy reports, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Heterogeneity of the VEXAS Syndrome

Mayo Clinic proceedings, 2021-10, Vol.96 (10), p.2653-2659

2021

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Haematologica (Roma), 2024-02, Vol.109 (2), p.689

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Acquired Sideroblastic Anemias

Hematology/oncology clinics of North America, 2020-04, Vol.34 (2), p.401-420

2020

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

American journal of hematology, 2019-07, Vol.94 (7), p.767-779

2019

Link zum Volltext

Verfügbarkeit prüfen

In Reply-Short Telomere Syndromes, Biological Aging, and Hematopoietic Stem Cell Transplantation

Mayo Clinic proceedings, 2018-11, Vol.93 (11), p.1685-1687

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 303

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(122)
Hematology
(98)
Humans
(89)
Oncology
(46)
Mutation
(42)
Male
(33)
Aged
(30)
Middle Aged
(29)
Female
(27)
Adult
(22)
Prognosis
(20)
Aged, 80 And Over
(17)
Physical Sciences
(17)
Leukemia
(16)
Retrospective Studies
(16)
Chemistry
(14)
Chronic Myelomonocytic Leukemia
(13)
Myeloproliferative Disorders - Genetics
(13)
Tumors
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(59)
Transplantation And Cellular Therapy
(26)
American Journal Of Hematology
(19)
Blood Cancer Journal
(14)
Journal Of Clinical Oncology
(12)
Blood Advances
(10)
Leukemia Research
(10)
Haematologica
(9)
Hemasphere
(9)
Leukemia
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population

Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia

Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"

P1323: PREDICTION OF NON‐RELAPSE MORTALITY BY EASIX AND HCT‐CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT

Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients

P730: GENETIC LANDSCAPE OF SOMATIC MYELOID MUTATIONS IN THE PRESENCE OF RARE TERT VARIANTS AND THEIR RELATION WITH MYELOID NEOPLASIA

Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation

Clinical Heterogeneity of the VEXAS Syndrome: A Case Series

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT‐NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders

Clinical Heterogeneity of the VEXAS Syndrome

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Treatment of Acquired Sideroblastic Anemias

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

In Reply-Short Telomere Syndromes, Biological Aging, and Hematopoietic Stem Cell Transplantation

Suchergebnisse filtern